R K BRAZZELL's Planned Sale of KALA BIO, Inc. Securities

R K BRAZZELL, an officer of KALA BIO, Inc., has filed a Form 144 notice indicating the planned sale of 46,748 common shares of KALA BIO, Inc. The securities to be sold were acquired through various means, including performance shares, restricted stock, exercised shares, and the Employee Stock Purchase Plan. The approximate sale date is set for October 22, 2025, with an aggregate market value of $38,963.76. The securities are held on NASDAQ, and the sale will be facilitated by Morgan Stanley Smith Barney LLC Executive Financial Services. No securities were sold in the past three months.